Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | MAMMOTH LIFESCIENCES LLPLikely | 1 | ₹1.9 L |
| 2 | Schedule 4 | SHRI VINAYAK PHARMALikely | 1 | ₹7,644 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
14 Aug 2025, 10:00 amClosed
Cough sedative syp each 5 ml containing Chlorpheniramine maleate 2.5 mg Guaiphenesiniramine 100 mg Noscapine 15 mg Sodium citrate 60 mg in flavoured base bott of 100 ml
Dulaglutide 1.5 mg per ml 0.5 ml PFS Inj
Dulaglutide 0.75 mg Solution for Injection 0.5 ml PFS
Perindopril 4 mg Tab
Herpes Zoster Vaccine Recombinant Adjuvanted
8083086
GEM/2025/B/6447503
Two Packet Bid
Cough sedative syp each 5 ml containing Chlorpheniramine
30 days
Maharashtra; Pune
Item wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹6 L
₹48 L
80%
Exempted
21 Aug 2025
30 Jul 2025
14 Aug 2025
| Item No | Item Title | Qty | Unit | Consignee | Delivery (days) | Spec |
|---|---|---|---|---|---|---|
| 1 | Cough sedative syp each 5 ml containing Chlorpheniramine maleate 2.5 mg Guaiphenesiniramine 100 mg Noscapine 15 mg Sodium citrate 60 mg in flavoured base bott of 100 ml | 6,900 | Bott | Pune | 30 | |
| 2 | Dulaglutide 1.5 mg per ml 0.5 ml PFS Inj | 105 | PFS | Pune | 30 | - |
| 3 | Dulaglutide 0.75 mg Solution for Injection 0.5 ml PFS | 250 | PFS | Pune | 30 | |
| 4 | Perindopril 4 mg Tab | 3,900 | No | Pune | 30 | - |
| 5 | Herpes Zoster Vaccine Recombinant Adjuvanted | 30 | No | Pune | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8083086.pdf
GEM_BID
re-46_spec___2025-07-13-09-36-26_a9b33f1c18676cb01c83faaa85044c47.pdf
BOQ
boq_item-_46_2025-07-13-09-36-26_289f4634e05ead97c9f6dea58b143c96.csv
BOQ
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .